SEC Form 4 · accession 0000914190-15-000035

Cardiovascular Systems Inc · CSII

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President and CEO · Director

Period of report

Feb 11, 2015

Accepted (ET)

Feb 13, 2015 · 6:02 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001180145

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Feb 11, 2015	S	1,000	$36.5548	D	371,689	D
Common Stock	holding	—	—		—	850	I	By child
Common Stock	holding	—	—		—	350	I	By child
Common Stock	holding	—	—		—	850	I	By child

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F3	$8.83	holding	—	—	—	—	Feb 14, 2017	Common Stock	20,800	20,800	D
Stock Option (right to buy)^F3	$7.90	holding	—	—	—	—	Jun 11, 2017	Common Stock	90,580	90,580	D
Stock Option (right to buy)^F3	$12.15	holding	—	—	—	—	Dec 11, 2017	Common Stock	234,395	234,395	D
Stock Option (right to buy)^F3	$8.75	holding	—	—	—	—	Mar 1, 2019	Common Stock	32,350	32,350	D

F1Sale of shares to provide funds to satisfy certain tax obligations of the reporting person.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.34 to $36.73 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3Fully exercisable.